Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In receptor pharmacology research, tesamorelin acts as a selective full agonist at the pituitary GHRHR, a class B G-protein-coupled receptor
Marketed initially in Canada and the United States, it is now available in Mexico, Central and South America, the Caribbean, Asia, and Europe
3ml syringes, 5 ×
Environmental factors like temperature, light, and moisture can compromise the product, leading to degradation of the benzyl alcohol preservative or even promoting microbial growth if conditions are unfavorable
The proportion of responders was statistically indistinguishable: Placebo - 48/118 (40.7%)
US$ 28.01
US$ 20.03
US$ 27.48
US$ 25.79
US$ 26.74
